Literature DB >> 2355439

Acute hepatic failure associated with the use of low-dose sustained-release niacin.

H N Hodis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2355439     DOI： 10.1001/jama.1990.03450020033012

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

1.  The bioavailability of sustained release nicotinic acid formulations.

Authors:  P J Neuvonen; L Roivas; K Laine; O Sundholm
Journal:  Br J Clin Pharmacol       Date:  1991-10       Impact factor: 4.335

2.  Niacin--the long and the short of it.

Authors:  M J Malloy; P H Frost; J P Kane
Journal:  West J Med       Date:  1991-10

3.  Fulminant hepatic failure following low-dose sustained-release niacin therapy in hospital.

Authors:  D J Fischer; L L Knight; R E Vestal
Journal:  West J Med       Date:  1991-10

Review 4.  How well tolerated are lipid-lowering drugs?

Authors:  B Tomlinson; P Chan; W Lan
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 5.  Novel oral drug formulations. Their potential in modulating adverse effects.

Authors:  A T Florence; P U Jani
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

Review 6.  Comparative tolerability of the HMG-CoA reductase inhibitors.

Authors:  J A Farmer; G Torre-Amione
Journal:  Drug Saf       Date:  2000-09       Impact factor: 5.606

Review 7.  Lipid-lowering agents that cause drug-induced hepatotoxicity.

Authors:  Sidharth S Bhardwaj; Naga Chalasani
Journal:  Clin Liver Dis       Date:  2007-08       Impact factor: 6.126
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.